Our findings demonstrate JQ1 can inhibit expression of E6 and E7 oncogenes as well as the cellulat oncogene c-MYC across the cell lines, suggesting BET inhibitors may be effective in treating HPV+ HNSCC. This evidence concerns the gene MYC and head and neck squamous cell carcinoma.